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Background: Diabetes and increased age are known risk factors for physical disability. With the increasing
prevalence of diabetes within our aging population, the future burden of disability is expected to increase. To date,
there has not been a pooled estimate of the risk for disability associated with diabetes or its precursor states,
impaired glucose tolerance and impaired fasting glucose. We aim to conduct a systematic review and meta-analysis
of the association between prediabetes and diabetes with disability, and quantify the risk of association.
Methods/design: We will search for relevant studies in Medline via Pubmed, Embase, Cochrane library and
Cumulative Index to Nursing and Allied Health Literature (CINAHL), as well as scan reference lists from relevant
reviews and publications included in our review. We will review all publications that include studies on human
adults (18 years and older) where information is included on diabetes status and at least one measure of disability
(Activities of Daily Living (ADL), Instrumental ADL (IADL) or functional/mobility limitation), and where a risk
association is available for the relationship between diabetes and/or prediabetes with disability, with reference to
those without diabetes.
We will further conduct a meta-analysis to pool estimates of the risk of disability associated with prediabetes and
diabetes. Sensitivity analysis will be conducted to assess for publication bias and study quality.Findings from this
systematic review and meta-analysis will be widely disseminated through discussions with stake-holders, publication
in a peer-reviewed journal and conference presentation.
Keywords: Diabetes, Impaired glucose tolerance, Physical disability, Functional limitation, Mobility limitation,
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With increasingly aging populations and increasing
prevalence of diabetes, there are fears that the gains in
healthy life expectancy that have been made may soon
be reversed. Estimations of the impact of these trends
on the burden of ill health and disability in old age
depend on accurate estimations of the associated risks.
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this association is unclear.
Diabetes mellitus is a metabolic condition character-
ized by hyperglycemia due to defects in insulin action or
secretion or both, resulting in end-organ damages such
as ischemic heart disease, chronic kidney disease,
strokes, peripheral neuropathy and peripheral vascular
disease [1]. Diabetes may lead to disability either via one
of the above mentioned pathways or independently [2].
Physical disability is defined by ‘long term limitations
in major activities of daily life’ [3]. There are various
measures of this limitation including limitations to acti-
vities such as feeding, washing, dressing, transferring in
and out of a chair or bed, and getting to and using a toi-
let, all of which can be categorized as limitations to self-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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are also used to measure disability and these can be self-
reported limitations to various walking tasks or mea-
sured functions such as walking-speed.
Estimates of the association between diabetes and dis-
ability vary. A study of a prospective cohort of elderly
Mexican-Americans free of disability at baseline (1993–
1994) reported that participants with diabetes were twice
as likely to report development of any limitation in
lower body disability during a seven-year follow-up (ha-
zard ratio (HR) 2.05, 95% confidence interval (CI) 1.58-
2.67) compared to those without diabetes [4]. Similarly,
a prospective study of elderly women, commenced in
1986, reported a HR of 1.42 (95% CI 1.23-1.65) [5]. In
contrast, a cross-sectional study in Taiwan, revealed that
for both men and women the risk of disability among
those with or without diabetes did not significantly differ
for men (odds ratio (OR) 1.1 (95% CI 0.6-2.2)) or
women (OR 1.7 (95% CI 0.7-4.2)) [6]. In a similar popu-
lation cross-sectional survey in Hong Kong, Chau et al.
reported an OR of 1.7 (95% CI 1.51-1.8) for disability in
those undergoing treatment for diabetes when compared
to those without diabetes [7].
Variations in these risk estimates are likely to reflect dif-
ferences in the measurement of disability, the populations
examined, baseline age of participants in the study, follow-
up time, diabetes duration, method of ascertaining dia-
betes and disability status, as well as confounders adjusted
for in multivariable regression models. Measurements of
disability in various studies to date have included self-
reported limitations to ADLs [4,7,8], instrumental ADLs
[5,8] or mobility tasks [4,5] and measured mobility limita-
tion such as a timed 8-foot walk [4], lower extremity func-
tion, balance [5], and hand function [9]. Several of these
studies have included only women.
Other factors which appear to influence the relation-
ship between diabetes and disability include age, sex,
education, smoking, lack of physical activity, ethnicity,
obesity and other comorbidities including depression
[2,10,11].‘Prediabetes’ defined by impaired glucose tole-
rance (IGT) or impaired fasting glucose (IFG) is an
intermediate state where glucose levels do not meet the
criteria for a diagnosis of diabetes but are above normal
accepted levels [1]. The risk of disability associated with
prediabetes is less studied. In a small cohort (n=88), an
increased risk of disability was observed for those having
diabetes for over 15 years and increased glycosylated
hemoglobin (HbA1C) but this was not the case for
short-term or newly diagnosed diabetes or those with
IGT [9].
We aim to conduct a systematic review of the asso-
ciation between diabetes, prediabetes and physical dis-
ability and quantify this relationship using a meta-analysis.
If sufficient data permit, we further aim to examine themoderating effect of sex, age and duration of diabetes on
the above mentioned associations.
Methods/Design
Literature search strategy
Our search strategy, selection of publications and the
reporting of results for the review will be conducted in
accordance with the PRISMA guidelines [12]. We will
search the following databases: Ovid Medline, Embase,
Cochrane library and Cumulative Index to Nursing and
Allied Health Literature (CINAHL). We will further scan
reference lists in relevant reviews and publications
retrieved for the purpose of our review. There will be no
initial limit on the date of publication. We will search
for publications with medical subject headings (MeSH)
and keywords in title, abstract and text for diabetes and
disability terms. The diabetes MeSH and keyword terms
will include ‘diabetes’, ‘glucose intolerance’, combined
with the operator ‘OR’. The disability MeSH terms will
include ‘activities of daily living’ and ‘disabled persons’
and the disability keywords will comprise ‘disabl*’, ‘dis-
abiliti*’, ‘limit*’ and ‘impair*’, where * indicates an open
ending to the word. Where terms are exploded, this will
be recorded. All disability MeSH and keyword terms will
be combined with the operator ‘OR’. Following the se-
parate searches for diabetes and disability terms, the
search will then be combined with the operator ‘AND’.
We will further limit our search to exclude all publica-
tions on animals only and on humans younger than 18
years of age. A limit will also be placed on type of stu-
dies to include only case-control studies, cohort studies,
cross-sectional studies and clinical trials.
Inclusion criteria
For inclusion, publications must present studies of
human adults (18 years of age and older) where informa-
tion is included on diabetes status and at least one mea-
sure of disability (ADL or functional/mobility limitation),
and where a risk association is reported for the relation-
ship between diabetes or prediabetes and disability com-
pared to no diabetes and disability. If there is more than
one publication from the same study, we will only include
the latest publication.
Types of studies
This review will include case-control, cross-sectional
and cohort studies as well as clinical trials.
Types of participants
Participants will be adults aged 18 years and older with
recorded status of diabetes (has diabetes, no diabetes or
has ‘prediabetes’) or impaired glucose tolerance and
physical disability or mobility limitation.
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on the type of diabetes. Diabetes can be classified as ges-
tational diabetes, Type 1 diabetes or Type 2 diabetes de-
pending on etiology. Diagnosis of diabetes can either be
made by physician or defined by available measured fast-
ing glucose or glucose tolerance test or self-reported.
Prediabetes is defined by having IFG (fasting plasma
glucose (FPG) levels ≥100 mg/dl (5.6 mmol/L) but <126
mg/dl (7.0 mmol/L)) or IGT (2-hour oral glucose tole-
rance test (OGTT) of ≥140 mg/dl (7.8 mmol/L) but
<200 mg/dl (11.1 mmol/L)) [1].
Types of outcome measures
Our outcome measure of interest will be disability
defined by limitation in one or more ADLs or in mobi-
lity. If possible, we will have three outcome measures:
(1) limitations to basic ADLs (such as bathing, dressing,
eating, getting in or out of bed, toileting); (2) limitations
to instrumental ADL’s (such as housework, shopping);
and (3) limitations to mobility (such as walking a certain
distance and going up and down stairs).
Once the search has been conducted, at least two
authors will cross check retrieved articles and make in-
dependent judgments as to which publications should be
included in the study. First, studies will be selected if the
title of the study is relevant. Next, the abstract will be
assessed to determine if the study satisfies the inclusion
criteria. If it is unclear from the abstract as to whether
selection criteria are met, the full article will be scanned.
Any discrepancy in study inclusion will be discussed
with a third or fourth author. Once the appropriate arti-
cles have been chosen for further analysis, two or three
authors will be involved in each article’s independent as-
sessment and extraction of data. Further studies may be
excluded as a result of not meeting the inclusion criteria.
Further studies may be included through searching
reference lists in publications selected for the review. All
included studies will be read in detail and relevant infor-
mation extracted.
Data extraction
From the selected publications, we will extract where
available: type of study design; year of study; length of
follow-up; person-years of follow-up; sample size; pro-
portion of men and women; age; population characteris-
tics (such as general population, health professionals,
ethnic composition); method used to ascertain diabetes
status; number of cases with disability; method used to
ascertain disability; incidence rate of disability; list of fac-
tors adjusted for; relative risk or equivalent associated
with pre-diabetes or diabetes; and disability. Effect sizes
will be extracted from multi-variable regression models
that adjusted for the most comprehensive set of plau-
sible confounders. If effect sizes are only available fromunadjusted models, these effect sizes will be extracted
and these studies will be noted in quality analysis.
Wherever possible, adjusted relative risk (RR) or equiva-
lent and associated 95% CI will be extracted directly from
studies. For studies that present RR for subgroups (for ex-
ample, sex) the data for each individual subgroup will be
additionally extracted. Authors will be contacted via email
for any missing relevant information.Data analysis
As disability is not rare, we will not be able to treat all
HRs, RRs and ORs as the same. If the data permit we
will either convert the effect size to the most common
form of estimate, or we will group studies by the type of
effect size and pool these different effect size estimates.
To pool relative effects, we will be using the Generic
Inverse Variance (GIV) method in Review Manager
(RevMan 5.1.7) software (The Nordic Cochrane Centre,
Copenhagen, Denmark). Log of the ratios of effect (RR,
OR or HR) and its standard error (SE) will be calculated
and entered into RevMan.
We plan to analyze the magnitude of association by
study design and therefore, we will pool point estimates
from groups of studies with the same study design.
Where data permit, we will further conduct a subgroup
analysis by age (<65 years of age versus ≥65 years of
age), sex and diabetes duration (<15 years since diagno-
sis versus ≥15 years since diagnosis). In these subgroup
analyses, significant differences in pooled effect size be-
tween subgroups will be tested using Revman 5.1.7.Assessment of heterogeneity and quality
A random effect model will be used as a conservative
approach as data is expected to vary across studies. He-
terogeneity will be tested using the chi-squared statistic,
where a P value less than 0.1 will be regarded as signifi-
cant heterogeneity [13]. Other assessments of heteroge-
neity will include I2 (I2 ≥75% equates to high heterogeneity
[14]) and visual inspection of the forest plot for inconsist-
encies in effect sizes and their confidence intervals. After
using the Newcastle-Ottawa Scale for study quality [15], a
separate analysis will be performed on studies with the
highest level of quality. A high-quality publication will be
defined as one that is a prospective cohort study with
disability-free participants at baseline, measured glucose
tests to diagnose diabetes or physician-diagnosed dia-
betes, and regression models adjusting for major cova-
riates. Where mobility limitation is a reported outcome,
measured mobility limitation will be considered as an
additional quality criterion.
If data permit, a metaregression will be conducted to
analyze for sources of heterogeneity.
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Symmetry of funnel plots will be used to assess for pub-
lication or selective reporting bias.
Discussion
This systematic review and meta-analysis will provide an
updated and quantitative estimate of the risk of disability
associated with prediabetes and diabetes compared to
those without. This pooled estimate will take into ac-
count factors which may confound or modify the rela-
tionship such as sex, socio-economic position, and
duration of diabetes, and will indicate the role of such
factors in the variability of reported estimates. This re-
view will include a wide number of study designs with a
subgroup analysis to study the effects of study design
and study quality on the estimate the risk association be-
tween diabetes and disability.
The findings from the review will be widely dissemi-
nated through discussions with stake-holders, publication
in a peer-reviewed journal and a conference presentation.
The pooled estimate will guide clinicians and policy
makers in informing patients and governments about the
risk of disability associated with diabetes, and will likely
aid the promotion of disability prevention measures. It will
further provide an estimate that can be used in future pro-
jections of disability prevalence in our aging population. A
systematic review on diabetes and disability will bring to
light knowledge gaps in the area and offer directions for
future research.
Abbreviations
ADL: activities of daily living; IADL: instrumental activities of daily living;
CINAHL: Cumulative Index to Nursing and Allied Health Literature;
FPG: fasting plasma glucose; HR: hazards ratio; IFG: impaired fasting glucose;
IGT: impaired glucose tolerance; MeSH: medical subject heading; OGTT: oral
glucose tolerance test; OR: odds ratio; PRISMA: preferred reporting items for
systematic reviews and meta-analyses; RR: risk ratio.
Competing interests
The authors declare that they have no competing interests.
Authors‘ contributions
EW was responsible for the- formulation of research question, design of
protocol, drafting the manuscript and was also responsible for manuscript
submission and responding to reviewer comments. KB -assisted with the
formulation of research question, design of protocol and commented on
manuscript drafts. JH, EG, CS and RFP -commented on manuscript drafts. AP
-assisted with formulation of research question, design of protocol and
commented on manuscript drafts. All authors read and approved the final
manuscript.
Acknowledgements
EW and JH are supported by Monash University Australian Postgraduate
Award (APA) and Baker IDI Bright Sparks Foundation Top-up Award, RFP is
supported by an APA, A.P. is supported by a VicHealth Fellowship. Funding is
also received from the Australian Research Council (Linkage Project Grant
12010041 & Discovery Grant 120103277) and the National Health and
Medical Research Council (Project Grant 1027215).
Author details
1Department of Epidemiology & Preventive Medicine, Faculty of Medicine,
Nursing & Health Sciences, School of Public Health and Preventive Medicine,Monash University, The Alfred Centre, Alfred Hospital, Commercial Road,
Melbourne, VIC 3004, Australia. 2BakerIDI Heart and Diabetes Institute, 99
Commercial Road, Melbourne, VIC 3004, Australia. 3School of Health and
Social Development, Faculty of Health, Deakin University, 221 Burwood
Highway, Burwood, VIC 3125, Australia.
Received: 19 July 2012 Accepted: 5 October 2012
Published: 17 October 2012
References
1. American Diabetes Association: Diagnosis and classification of diabetes
mellitus. Diabetes Care 2006, Suppl 1:43–48.
2. Lu F-P, Lin K-P, Kuo H-K: Diabetes and the risk of multi-system aging
phenotypes: a systematic review and meta-analysis. PLoS One 2009,
4:e4144.
3. De Bruin A, Picavet HS, Nossikov A: Health interview surveys. Towards
international harmonization of methods and instruments. WHO Reg Publ
Eur Ser 1996, 58:1–161.
4. Al Snih S, Fisher MN, Raji MA, Markides KS, Ostir GV, Goodwin JS: Diabetes
mellitus and incidence of lower body disability among older Mexican
Americans. J Gerontol Ser A Biol Sci Med Sci 2005, 60:1152–1156.
5. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM,
Narayan KM: Diabetes and physical disability among older U.S. adults.
Diabetes Care 2000, 23:1272–1277.
6. Wu CH, Chen CY, Wu YC, Weng LJ, Baai-Shyun H: Diabetes mellitus and
functional impairment in Taiwanese older men and women. Arch
Gerontol Geriatr 2010, Suppl 1:6–10.
7. Chau PH, Woo J, Lee CH, Cheung WL, Chen J, Chan WM, Hui L, McGhee SM:
Older people with diabetes have higher risk of depression, cognitive
and functional impairments: implications for diabetes services. J Nutr
Health Aging 2011, 15:751–755.
8. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH: Diabetes as a
predictor of change in functional status among older Mexican Americans:
a population-based cohort study. Diabetes Care 2003, 26:314–319.
9. Cederlund RI, Thomsen N, Thrainsdottir S, Eriksson KF, Sundkvist G, Dahlin LB:
Hand disorders, hand function, and activities of daily living in elderly men
with type 2 diabetes. J Diabetes Complications 2009, 23:32–39.
10. Volpato S, Maraldi C, Fellin R: Type 2 Diabetes and Risk for Functional
Decline and Disability in Older Persons. Curr Diabetes Rev 2010, 6:134–143.
11. Bruce DG, Davis WA, Davis TM: Longitudinal predictors of reduced
mobility and physical disability in patients with type 2 diabetes: the
Fremantle Diabetes Study. Diabetes Care 2005, 28:2441–2447.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group: Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement. PLoS Med 2009, 6:e1000097.
13. Higgins JPT, Thompson SG: Quantifying heterogeneity in a meta-analysis.
Stat Med 2002, 21:1539–1558.
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency
in meta-analyses. BMJ 2003, 327:557–560.
15. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The
Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses. [http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp].
doi:10.1186/2046-4053-1-47
Cite this article as: Wong et al.: A systematic review and meta-analysis
of diabetes and risk of physical disability and functional impairment -
protocol. Systematic Reviews 2012 1:47.
